Use of a novel cell-based fusion reporter assay to explore the host range of human respiratory syncytial virus F protein.

Human respiratory syncytial virus (HRSV) is an important respiratory pathogen primarily affecting infants, young children, transplant recipients and the elderly. The F protein is the only virion envelope protein necessary and sufficient for virus replication and fusion of the viral envelope membrane with the target host cell. During natural infection, HRSV replication is limited to respiratory epithelial cells with disseminated infection rarely, if ever, occurring even in immunocompromised patients. However, in vitro infection of multiple human and non-human cell types other than those of pulmonary tract origin has been reported. To better define host cell surface molecules that mediate viral entry and dissect the factors controlling permissivity for HRSV, we explored the host range of HRSV F protein mediated fusion. Using a novel recombinant reporter gene based fusion assay, HRSV F protein was shown to mediate fusion with cells derived from a wide range of vertebrate species including human, feline, equine, canine, bat, rodent, avian, porcine and even amphibian (Xenopus). That finding was extended using a recombinant HRSV engineered to express green fluorescent protein (GFP), to confirm that viral mRNA expression is limited in several cell types. These findings suggest that HRSV F protein interacts with either highly conserved host cell surface molecules or can use multiple mechanisms to enter cells, and that the primary determinants of HRSV host range are at steps post-entry.

[1]  J. Devincenzo,et al.  Natural Infection of Infants with Respiratory Syncytial Virus Subgroups A and B: A Study of Frequency, Disease Severity, and Viral Load , 2004, Pediatric Research.

[2]  R. Rabin,et al.  Suppression of the Induction of Alpha, Beta, and Lambda Interferons by the NS1 and NS2 Proteins of Human Respiratory Syncytial Virus in Human Epithelial Cells and Macrophages , 2004, Journal of Virology.

[3]  M. Parker,et al.  Structural characterization of respiratory syncytial virus fusion inhibitor escape mutants: homology model of the F protein and a syncytium formation assay. , 2003, Virology.

[4]  T. Nakayama,et al.  Detection of human respiratory syncytial virus sequences in peripheral blood mononuclear cells , 2003, Journal of medical virology.

[5]  K. Conzelmann,et al.  Respiratory Syncytial Virus (RSV) Fusion Protein Subunit F2, Not Attachment Protein G, Determines the Specificity of RSV Infection , 2003, Journal of Virology.

[6]  Lin-Fa Wang,et al.  Membrane Fusion Tropism and Heterotypic Functional Activities of the Nipah Virus and Hendra Virus Envelope Glycoproteins , 2002, Journal of Virology.

[7]  F. Hayden,et al.  Viral infections in immunocompromised patients: what's new with respiratory viruses? , 2002, Current opinion in infectious diseases.

[8]  P. Collins,et al.  Respiratory Syncytial Virus Infection of Human Airway Epithelial Cells Is Polarized, Specific to Ciliated Cells, and without Obvious Cytopathology , 2002, Journal of Virology.

[9]  K. Conzelmann,et al.  Respiratory Syncytial Virus (RSV) Nonstructural (NS) Proteins as Host Range Determinants: a Chimeric Bovine RSV with NS Genes from Human RSV Is Attenuated in Interferon-Competent Bovine Cells , 2002, Journal of Virology.

[10]  B. Gómez,et al.  Characteristics of a respiratory syncytial virus persistently infected macrophage-like culture. , 2002, Virus research.

[11]  P. Collins,et al.  Respiratory syncytial virus with the fusion protein as its only viral glycoprotein is less dependent on cellular glycosaminoglycans for attachment than complete virus. , 2002, Virology.

[12]  L. Anderson,et al.  Involvement of Toll-Like Receptor 4 in Innate Immunity to Respiratory Syncytial Virus , 2001, Journal of Virology.

[13]  P. Collins,et al.  Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo. , 2001, Virology.

[14]  J. Skehel,et al.  Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Peeples,et al.  Functional Analysis of Recombinant Respiratory Syncytial Virus Deletion Mutants Lacking the Small Hydrophobic and/or Attachment Glycoprotein Gene , 2001, Journal of Virology.

[16]  J. Barenfanger,et al.  R-Mix cells are faster, at least as sensitive and marginally more costly than conventional cell lines for the detection of respiratory viruses. , 2001, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[17]  K. Meyer,et al.  Immunoregulatory role of secreted glycoprotein G from respiratory syncytial virus. , 2001, Virus research.

[18]  R. Sugrue,et al.  Furin cleavage of the respiratory syncytial virus fusion protein is not a requirement for its transport to the surface of virus-infected cells. , 2001, The Journal of general virology.

[19]  P S Kim,et al.  Structural characterization of the human respiratory syncytial virus fusion protein core. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[20]  D. Spillmann,et al.  Glycosaminoglycan Sulfation Requirements for Respiratory Syncytial Virus Infection , 2000, Journal of Virology.

[21]  J. Melero,et al.  Binding of human respiratory syncytial virus to cells: implication of sulfated cell surface proteoglycans. , 2000, The Journal of general virology.

[22]  J. White,et al.  Heptad-repeat regions of respiratory syncytial virus F1 protein form a six-membered coiled-coil complex. , 2000, Biochemistry.

[23]  H. Jin,et al.  Recombinant respiratory syncytial viruses with deletions in the NS1, NS2, SH, and M2-2 genes are attenuated in vitro and in vivo. , 2000, Virology.

[24]  S. Feldman,et al.  The Fusion Glycoprotein of Human Respiratory Syncytial Virus Facilitates Virus Attachment and Infectivity via an Interaction with Cellular Heparan Sulfate , 2000, Journal of Virology.

[25]  L. Anderson,et al.  Respiratory Syncytial Virus G and/or SH Glycoproteins Modify CC and CXC Chemokine mRNA Expression in the BALB/c Mouse , 2000, Journal of Virology.

[26]  Joel P. Mackay,et al.  The Core of the Respiratory Syncytial Virus Fusion Protein Is a Trimeric Coiled Coil , 2000, Journal of Virology.

[27]  P. Collins,et al.  Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection. , 2000, Virology.

[28]  L. Pedersen,et al.  Cleavage of the respiratory syncytial virus fusion protein is required for its surface expression: role of furin. , 2000, Virus research.

[29]  YUNG-TSEN Huang,et al.  Mink Lung Cells and Mixed Mink Lung and A549 Cells for Rapid Detection of Influenza Virus and Other Respiratory Viruses , 2000, Journal of Clinical Microbiology.

[30]  J. Mills,et al.  Surfactant protein A binds to the fusion glycoprotein of respiratory syncytial virus and neutralizes virion infectivity. , 1999, The Journal of infectious diseases.

[31]  Robert B Sim,et al.  A recombinant trimeric surfactant protein D carbohydrate recognition domain inhibits respiratory syncytial virus infection in vitro and in vivo , 1999, European journal of immunology.

[32]  R. Holman,et al.  Bronchiolitis-associated hospitalizations among US children, 1980-1996. , 1999, JAMA.

[33]  M. St. Claire,et al.  Recombinant Respiratory Syncytial Virus Bearing a Deletion of either the NS2 or SH Gene Is Attenuated in Chimpanzees , 1999, Journal of Virology.

[34]  P. Pothier,et al.  Heparin-Like Structures on Respiratory Syncytial Virus Are Involved in Its Infectivity In Vitro , 1998, Journal of Virology.

[35]  P. Collins,et al.  Identification of the Respiratory Syncytial Virus Proteins Required for Formation and Passage of Helper-Dependent Infectious Particles , 1998, Journal of Virology.

[36]  S S Whitehead,et al.  Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[37]  B. Murphy,et al.  Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse , 1997, Journal of virology.

[38]  S. Dowell,et al.  Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. , 1996, The Journal of infectious diseases.

[39]  S. Alexandersen,et al.  Sites of Replication of Bovine Respiratory Syncytial Virus in Naturally Infected Calves as Determined by In Situ Hybridization , 1996, Veterinary pathology.

[40]  R. Chanock,et al.  Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Y. Tanaka,et al.  Analysis of respiratory syncytial virus F, G, and SH proteins in cell fusion. , 1994, Virology.

[42]  A. Villani,et al.  Restricted replication of respiratory syncytial virus in human alveolar macrophages. , 1993, The Journal of general virology.

[43]  J. Hierholzer,et al.  Sensitivity of NCI-H292 human lung mucoepidermoid cells for respiratory and other human viruses , 1993, Journal of clinical microbiology.

[44]  P. Collins,et al.  Post-translational processing and oligomerization of the fusion glycoprotein of human respiratory syncytial virus. , 1991, The Journal of general virology.

[45]  J. Sinnott,et al.  Respiratory Syncytial Virus , 1988, Infection Control & Hospital Epidemiology.

[46]  W. P. Glezen,et al.  Risk of primary infection and reinfection with respiratory syncytial virus. , 1986, American journal of diseases of children.

[47]  C. Pringle,et al.  Pneumoviruses: the cell surface of lytically and persistently infected cells. , 1979, The Journal of general virology.

[48]  R. Chanock,et al.  Temperature-sensitive mutants of respiratory syncytial virus: in-vivo studies in hamsters. , 1970, The Journal of infectious diseases.

[49]  T. Braciale,et al.  Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract , 2002, Nature Medicine.

[50]  R. Sugrue,et al.  Multiple glycosylated forms of the respiratory syncytial virus fusion protein are expressed in virus-infected cells. , 2002, The Journal of general virology.

[51]  R. Holman,et al.  Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. , 2001, The Journal of infectious diseases.

[52]  J. Alexander,et al.  Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. , 1999, The Journal of infectious diseases.

[53]  T. Krusat,et al.  Heparin-dependent attachment ofrespiratory syncytial virus (RSV) to host cells , 1997, Archives of Virology.